These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2880978)

  • 1. Identification of two metabolites of the cholinesterase reactivator HI-6 isolated from rat urine.
    Ligtenstein DA; Wils ER; Kossen SP; Hulst AG
    J Pharm Pharmacol; 1987 Jan; 39(1):17-23. PubMed ID: 2880978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatography analysis of by-products and intermediates arising during the synthesis of the acetylcholinesterase reactivator HI-6.
    Jun D; Stodulka P; Kuca K; Dolezal B
    J Chromatogr Sci; 2010 Sep; 48(8):694-6. PubMed ID: 20819302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobehavioral effects of the pyridinium aldoxime cholinesterase reactivator HI-6.
    Liu WF; Shih JH
    Neurotoxicol Teratol; 1990; 12(1):73-8. PubMed ID: 2314363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo metabolisms of K-48.
    Benko B; Kalász H; Ludányi K; Petroianu G; Kuca K; Darvas F; Tekes K
    Anal Bioanal Chem; 2007 Oct; 389(4):1243-7. PubMed ID: 17768608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of K-27, an oxime-type cholinesterase reactivator by high-performance liquid chromatography with electrochemical detection from different biological samples.
    Gyenge M; Kalász H; Petroianu GA; Laufer R; Kuca K; Tekes K
    J Chromatogr A; 2007 Aug; 1161(1-2):146-51. PubMed ID: 17603065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships in reactivators of organophosphorus-inhibited acetylcholinesterase. 10. Hydroxyiminomethylarylethenylpyridine methiodides.
    Arena F; Manna F; Pizza C; Stein ML; Grifantini M
    J Med Chem; 1975 Nov; 18(11):1147-50. PubMed ID: 1177261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purity of antidotal oxime HI-6 DMS as an active pharmaceutical ingredient for auto-injectors and infusions.
    Bogan R; Koller M; Klaubert B
    Drug Test Anal; 2012; 4(3-4):199-207. PubMed ID: 22362586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLC analysis of intermediates arising during the preparation of oxime HI-6 dimethanesulfonate.
    Jun D; Stodulka P; Kuca K; Koleckar V; Dolezal B; Simon P; Veverka M
    J Chromatogr Sci; 2008 Apr; 46(4):316-9. PubMed ID: 18402722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of novel phenoxyalkyl pyridinium oximes as brain-penetrating reactivators of cholinesterase inhibited by surrogates of sarin and VX.
    Chambers JE; Chambers HW; Funck KE; Meek EC; Pringle RB; Ross MK
    Chem Biol Interact; 2016 Nov; 259(Pt B):154-159. PubMed ID: 27387540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic profile in blood and brain of the cholinesterase reactivating oxime HI-6 after intravenous administration to the rat.
    Ligtenstein DA; Kossen SP
    Toxicol Appl Pharmacol; 1983 Nov; 71(2):177-83. PubMed ID: 6636183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium.
    Luo C; Saxena A; Smith M; Garcia G; Radić Z; Taylor P; Doctor BP
    Biochemistry; 1999 Aug; 38(31):9937-47. PubMed ID: 10433700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
    Kassa J; Jun D; Kuca K
    J Enzyme Inhib Med Chem; 2007 Jun; 22(3):297-300. PubMed ID: 17674811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary metabolites of 2,6-diisopropylnaphthalene in rats.
    Kojima S; Honda T; Nakagawa M; Kiyozumi M; Takadate A
    Drug Metab Dispos; 1982; 10(4):429-33. PubMed ID: 6126346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and quantification of metabolites of 2,3,5,6-tetrafluoro-4-trifluoromethylaniline in rat urine using 19F nuclear magnetic resonance spectroscopy, high-performance liquid chromatography-nuclear magnetic resonance spectroscopy and high-performance liquid chromatography-mass spectrometry.
    Scarfe GB; Clayton E; Wilson ID; Nicholson JK
    J Chromatogr B Biomed Sci Appl; 2000 Oct; 748(1):311-9. PubMed ID: 11092607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
    Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new H-oxime restores rat diaphragm contractility after esterase inhibition in vitro.
    Alberts P
    Eur J Pharmacol; 1990 Aug; 184(1):191-4. PubMed ID: 2209712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic determination of the plasma concentration of K-27, a novel oxime-type cholinesterase reactivator.
    Tekes K; Hasan MY; Sheen R; Kuca K; Petroianu G; Ludányi K; Kalász H
    J Chromatogr A; 2006 Jul; 1122(1-2):84-7. PubMed ID: 16690067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo distribution of organophosphate antidotes: autoradiography of [14C]HI-6 in the rat.
    Ligtenstein DA; Moes GW; Kossen SP
    Toxicol Appl Pharmacol; 1988 Feb; 92(2):324-9. PubMed ID: 3341040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
    Kuca K; Cabal J
    Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics, distribution, and biotransformation of the chemical HI-6 in the rat, dog, and rhesus monkey.
    Ecobichon DJ; Comeau AM; O'Neil WM; Marshall WD
    Can J Physiol Pharmacol; 1990 May; 68(5):614-21. PubMed ID: 2340450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.